DBV Technologies General Meeting Announcement
Analysis based on 6 articles · First reported May 13, 2026 · Last updated May 13, 2026
The event is a routine corporate governance activity for DBV Technologies, providing transparency to shareholders. It is unlikely to have a significant direct impact on the broader financial markets, but may influence investor sentiment for DBV Technologies depending on the resolutions discussed and approved.
DBV Technologies, a late-stage biopharmaceutical company, announced that it will hold its Combined General Meeting on June 3, 2026, at its headquarters in Châtillon, France. The company has published the preliminary and meeting notices in the French 'Bulletin des Annonces Légales Obligatoires (BALO)' and Les Affiches parisiennes. Information and preparatory documents for the meeting are available on DBV Technologies' website for shareholders, and the meeting will be webcast live.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard